Back to results
US 2023/0398097 A1Published application
Carboxylated psilocybin derivatives and methods of using
AssigneeEnveric Biosciences Canada Inc.
InventorsJillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
Life of this patent
Estimating the term…
Abstract
Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
Claims20
A method for treating a psychiatric disorder, the method comprising administering to a subject in need thereof a pharmaceutical formulation comprising a chemical compound having the formula (I):
- wherein, at least one of R2, R5, R6, or R7 is a carboxyl group or a carboxylic acid derivative, and wherein each non-carboxylated R2, R5, R6, or R7 is a hydrogen atom, an alkyl group, or O-alkyl group, wherein R4 is an O-alkyl group, an O-acyl group, a hydroxy group, a phosphate group, a glycosyloxy group, or a hydrogen atom and wherein R3A and R3B are each independently a hydrogen atom, an alkyl group, acyl group or an aryl group, wherein the pharmaceutical formulation is administered in an effective amount to treat the psychiatric disorder in the subject.
Dependencies are inferred from the claim text.